
FDA Response Letter to AdvaMed®’s UDI Cross Reference Proposal
FDA sent this letter in response to issues AdvaMed® raised to the FDA regarding implementation of the UDI rule.
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.

FDA sent this letter in response to issues AdvaMed® raised to the FDA regarding implementation of the UDI rule.
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.

This report presents estimates of the national impact of the industry, extracted from the most recent business data from the 2012 Economic Census.
Medical technology delivers value every day. It represents a small and stable part of national health spending and prices have remained very competitive.